These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 24468658)

  • 21. Evidences of Reduced Antioxidant Activity in Patients With Chronic Migraine and Medication-Overuse Headache.
    Lucchesi C; Baldacci F; Cafalli M; Chico L; Lo Gerfo A; Bonuccelli U; Siciliano G; Gori S
    Headache; 2015; 55(7):984-91. PubMed ID: 26129705
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mindfulness and pharmacological prophylaxis after withdrawal from medication overuse in patients with Chronic Migraine: an effectiveness trial with a one-year follow-up.
    Grazzi L; Sansone E; Raggi A; D'Amico D; De Giorgio A; Leonardi M; De Torres L; Salgado-García F; Andrasik F
    J Headache Pain; 2017 Dec; 18(1):15. PubMed ID: 28161874
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Real-life data in 115 chronic migraine patients treated with Onabotulinumtoxin A during more than one year.
    Aicua-Rapun I; Martínez-Velasco E; Rojo A; Hernando A; Ruiz M; Carreres A; Porqueres E; Herrero S; Iglesias F; Guerrero AL
    J Headache Pain; 2016 Dec; 17(1):112. PubMed ID: 27957623
    [TBL] [Abstract][Full Text] [Related]  

  • 24. SumaRT/Nap vs naproxen sodium in treatment and disease modification of migraine: a pilot study.
    Cady R; O'Carroll P; Dexter K; Freitag F; Shade CL
    Headache; 2014 Jan; 54(1):67-79. PubMed ID: 24021029
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Topiramate reduces headache days in chronic migraine: a randomized, double-blind, placebo-controlled study.
    Diener HC; Bussone G; Van Oene JC; Lahaye M; Schwalen S; Goadsby PJ;
    Cephalalgia; 2007 Jul; 27(7):814-23. PubMed ID: 17441971
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anti-CGRP monoclonal antibodies in chronic migraine with medication overuse: real-life effectiveness and predictors of response at 6 months.
    Caronna E; Gallardo VJ; Alpuente A; Torres-Ferrus M; Pozo-Rosich P
    J Headache Pain; 2021 Oct; 22(1):120. PubMed ID: 34620085
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Are depressive symptomatology, self-efficacy, and perceived social support related to disability and quality of life in patients with chronic migraine associated to medication overuse? Data from a cross-sectional study.
    D'Amico D; Grazzi L; Bussone G; Curone M; Di Fiore P; Usai S; Leonardi M; Giovannetti AM; Schiavolin S; Raggi A
    Headache; 2015 May; 55(5):636-45. PubMed ID: 25913219
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interictal increase of CGRP levels in peripheral blood as a biomarker for chronic migraine.
    Cernuda-Morollón E; Larrosa D; Ramón C; Vega J; Martínez-Camblor P; Pascual J
    Neurology; 2013 Oct; 81(14):1191-6. PubMed ID: 23975872
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Asthma is a risk factor for new onset chronic migraine: Results from the American migraine prevalence and prevention study.
    Martin VT; Fanning KM; Serrano D; Buse DC; Reed ML; Lipton RB
    Headache; 2016 Jan; 56(1):118-31. PubMed ID: 26581563
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Advice alone vs. structured detoxification programmes for medication overuse headache: a prospective, randomized, open-label trial in transformed migraine patients with low medical needs.
    Rossi P; Di Lorenzo C; Faroni J; Cesarino F; Nappi G
    Cephalalgia; 2006 Sep; 26(9):1097-105. PubMed ID: 16919060
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Disability in chronic migraine patients with medication overuse: treatment effects at 1-year follow-up.
    Grazzi L; Andrasik F; D'Amico D; Usai S; Kass S; Bussone G
    Headache; 2004; 44(7):678-83. PubMed ID: 15209690
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sumatriptan-naproxen and butalbital: a double-blind, placebo-controlled crossover study.
    Derosier F; Sheftell F; Silberstein S; Cady R; Ruoff G; Krishen A; Peykamian M
    Headache; 2012 Apr; 52(4):530-43. PubMed ID: 22103635
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pain catastrophising in a population of patients with migraine.
    Alvarez-Astorga A; García-Azorín D; Hernández M; de la Red H; Sotelo E; Uribe F; Guerrero AL
    Neurologia (Engl Ed); 2021; 36(1):24-28. PubMed ID: 30857787
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Analysis of leukocytes in medication-overuse headache, chronic migraine, and episodic migraine.
    Forcelini CM; Dantas DC; Luz C; Santin R; Stein AT; Barros HM; Barea LM
    Headache; 2011 Sep; 51(8):1228-38. PubMed ID: 21649652
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Probable medication-overuse headache: the effect of a 2-month drug-free period.
    Zeeberg P; Olesen J; Jensen R
    Neurology; 2006 Jun; 66(12):1894-8. PubMed ID: 16707727
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Elimination of menstrual-related migraine beneficially impacts chronification and medication overuse.
    Calhoun A; Ford S
    Headache; 2008 Sep; 48(8):1186-93. PubMed ID: 18819179
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of chronic migraine: a 3-month comparator study of naproxen sodium vs SumaRT/Nap.
    Cady R; Nett R; Dexter K; Freitag F; Beach ME; Manley HR
    Headache; 2014 Jan; 54(1):80-93. PubMed ID: 24020994
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Utility of topiramate for the treatment of patients with chronic migraine in the presence or absence of acute medication overuse.
    Diener HC; Dodick DW; Goadsby PJ; Bigal ME; Bussone G; Silberstein SD; Mathew N; Ascher S; Morein J; Hulihan JF; Biondi DM; Greenberg SJ
    Cephalalgia; 2009 Oct; 29(10):1021-7. PubMed ID: 19735529
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Patient-Centered Treatment of Chronic Migraine With Medication Overuse: A Prospective, Randomized, Pragmatic Clinical Trial.
    Schwedt TJ; Hentz JG; Sahai-Srivastava S; Murinova N; Spare NM; Treppendahl C; Martin VT; Birlea M; Digre K; Watson D; Leonard M; Robert T; Dodick DW;
    Neurology; 2022 Apr; 98(14):e1409-e1421. PubMed ID: 35169011
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Persistent frequent nausea is associated with progression to chronic migraine: AMPP study results.
    Reed ML; Fanning KM; Serrano D; Buse DC; Lipton RB
    Headache; 2015 Jan; 55(1):76-87. PubMed ID: 25250833
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.